Stage II endometrioid adenocarcinoma of the endometrium: Clinical implications of cervical stromal invasion

Gynecologic Oncology

Volumn 113, Issue 3, 2009, Pages 316-323

  Orezzoli, Jorge P ^a   Sioletic, Stefano ^b   Olawaiye, Alexander ^c   Oliva, Esther ^d   del Carmen, Marcela G ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer; Endometrial; Invasion; Stromal

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 67349199537     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.007     Document Type: Article

References (58)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics 2007. CA Cancer J. Clin. 57 (2007) 43-66
2. Homesley H.D. Revised 1988 International Federation of Gynecology and Obstetrics staging systems for endometrial and vulvar cancer: an assessment. Clin. Obstet. Gynecol. 35 (1992) 89-94
3. Gal D., Recio F.O., and Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer 69 (1992) 200-202
4. Creasman W., Morrow C.P., Bundy B.N., Omesley H.D., Raham J.E., and Eller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60 (1987) 2035-2041
5. Boronow R.C. Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge-a personal perspective. Gynecol. Oncol. 66 (1997) 179-189
6. Chambers S.K., Kapp D.S., Peschel R.E., Lawrence R., Merino M., Kohorn E.I., et al. Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinoma. Gynecol. Oncol. 27 (1987) 180-188
7. Trimble E.L., and Jones III H.W. Management of stage II endometrial adenocarcinoma. Obstet. Gynecol. 71 (1988) 323-326
8. Creasman W.T., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Heintz A.P., et al. Carcinoma of the corpus uteri. J. Epidemiol. Biostat. 6 (2001) 47-86
9. Creasmam W.T. FIGO Stages. 1988 Revision. Gynecol. Oncol. 35 (1989) 125-126
10. Zaino R.J., Kurman R.J., Diana K.L., and Morrow C.P. Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage-a Gynecologic Oncology Group study. Cancer 77 (1996) 1115-1121
11. Steiner E., Eicher O., Sagemuller J., Schmidt M., Pilch H., Tanner B., et al. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int. J. Gynecol. Cancer. 13 (2003) 197-203
12. Abeler V.M., and Kjorstad K.E. Endometrial adenocarcinoma in Norway. A study of a total population. Cancer 67 (1991) 3093-3103
13. Gal D., Recio F.O., and Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer 69 (1992) 200-202
14. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 (1994) 31-46
15. Abeler V.M., Vergote I.B., Kjorstad K.E., and Trope C.G. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78 (1996) 1740-1747
16. Al K.A., Lim P., Aquino-Parsons C., and Gilks C.B. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Mod. Pathol. 15 (2002) 365-371
17. Wolfson A.H., Sightler S.E., Markoe A.M., Schwade J.G., Averette H.E., Ganjei P., et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol. Oncol. 45 (1992) 142-146
18. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40 (1991) 55-65
19. Fanning J., Alvarez P.M., Tsukada Y., and Piver M.S. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol. Oncol. 40 (1991) 46-47
20. Kadar N.R., Kohorn E.I., LiVolsi V.A., and Kapp D.S. Histologic variants of cervical involvement by endometrial carcinoma. Obstet. Gynecol. 59 (1982) 85-92
21. Eltabbakh G.H., and Moore A.D. Survival of women with surgical stage II endometrial cancer. Gynecol. Oncol. 74 (1999) 80-85
22. Jordan L.B., and Al-Nafussi A. Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma. Int. J. Gynecol. Cancer 12 (2002) 42-48
23. Tambouret R., Clement P.B., and Young R.H. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Am. J. Surg. Pathol. 27 (2003) 1080-1088
24. Boronow R.C., Morrow C.P., Creasman W.T., DiSaia P.J., Silverberg S.G., Miller A., et al. Surgical staging in endometrial cancer: clinical pathologic findings of a prospective study. Obstet. Gynecol. 63 (1984) 825-832
25. Zaino R.J. Conventional and novel prognostic factors in endometrial and adenocarcinoma: a critical appraisal. Pathol. Case Rev. 5 (2000) 138-152
26. Yamazawa K., Seki K., Matsui H., and Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 91 (2001) 1777-1784
27. Briet J.M., Hollema H., Reesink N., Aalders J.G., Mourits M.J., ten Hoor K.A., et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol. Oncol. 96 (2005) 799-804
28. Cohn D.E., Horowitz N.S., Mutch D.G., Kim S.M., Manolitsas T., and Fowler J.M. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?. Gynecol. Oncol. 87 (2002) 243-246
29. Stefansson I.M., Salvesen H.B., Immervoll H., and Akslen L.A. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology 44 (2004) 472-479
30. Lee K.R., Vacek P.M., and Belinson J.L. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol. Oncol. 54 (1994) 10-18
31. Pitson G., Colgan T., Levin W., Lockwood G., Manchul L., Milosevic M., et al. Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 862-867
32. Ambros R.A., and Kurman R.J. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69 (1992) 1424-1431
33. Hanson M.B., van Nagell J.R.J., Powell D.E., Donaldson E.S., Gallion H., Merhige M., et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 55 (1985) 1753-1757
34. Kadar N., Homesley H.D., and Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol. Oncol. 46 (1992) 145-149
35. Shah C., Johnson E.B., Everett E., Tamimi H., Greer B., Swisher E., et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol. Oncol. 99 (2005) 564-570
36. Sivridis E., Buckley C.H., and Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br. J. Obstet. Gynaecol. 94 (1987) 991-994
37. Gal D., Recio F.O., Zamurovic D., and Tancer M.L. Lymphvascular space involvement-a prognostic indicator in endometrial adenocarcinoma. Gynecol. Oncol. 42 (1991) 142-145
38. Watari H., Todo Y., Takeda M., Ebina Y., Yamamoto R., and Sakuragi N. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol. Oncol. 96 (2005) 651-657
39. Abeler V.M., Kjorstad K.E., and Berle E. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int. J. Gynecol. Cancer 2 (1992) 9-22
40. DiSaia P.J., Creasman W.T., Boronow R.C., and Blessing J.A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am. J. Obstet. Gynecol. 151 (1985) 1009-1015
41. Konski A., Domenico D., Tyrkus M., Irving D., Neisler J., Phibbs G., et al. Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 35 (1996) 935-940
42. Creasman W.T., Odicino F., Maisonneuve P., Quinn M.A., Beller U., Benedet J.L., et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the results of treatment in gynecological cancer. Int. J. Gynaecol. Obstet. Suppl 1 (2006) S105-S143
43. Feltmate C.M., Duska L.R., Chang Y., Flynn C.E., Nikrui N., Kiggundu E., et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol. Oncol. 73 (1999) 407-411
44. Mariani A., Webb M.J., Keeney G.L., Calori G., and Podratz K.C. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol. Oncol. 83 (2001) 72-80
45. Cornelison T.L., Trimble E.L., and Kosary C.L. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol. Oncol. 74 (1999) 350-355
46. Sartori E., Gadducci A., Landoni F., Lissoni A., Maggino T., Zola P., et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int. J. Gynecol. Cancer 11 (2001) 430-437
47. Cohn D.E., Woeste E.M., Cacchio S., Zanagnolo V.L., Havrilesky L.J., Mariani A., et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet. Gynecol. 109 (2007) 1062-1067
48. Creasman W.T., DeGeest K., DiSaia P.J., and Zaino R.J. Significance of true surgical pathologic staging: a Gynecologic Oncology Group study. Am. J. Obstet. Gynecol. 181 (1999) 31-34
49. Rutledge F. The role of radical hysterectomy in adenocarcinoma of the endometrium. Gynecol. Oncol. 2 (1974) 331-347
50. Barwick T.D., Rockall A.G., Barton D.P., and Sohaib S.A. Imaging of endometrial adenocarcinoma. Clin. Radiol. 61 (2006) 545-555
51. Seki H., Takano T., and Sakai K. Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. Am. J. Roentgenol. 175 (2000) 171-176
52. Manfredi R., Gui B., Maresca G., Fanfani F., and Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom. Imaging 30 (2005) 626-636
53. Manfredi R., Mirk P., Maresca G., Margariti P.A., Testa A., Zannoni G.F., et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231 (2004) 372-378
54. Ayhan A., Taskiran C., Celik C., and Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol. Oncol. 93 (2004) 9-13
55. Straughn Jr. J.M., Numnum T.M., Kilgore L.C., Partridge E.E., Phillips J.L., Markman M., et al. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol. Oncol. 99 (2005) 530-535
56. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92 (2004) 744-751
57. Lachance J.A., Everett E.N., Greer B., Mandel L., Swisher E., Tamimi H., et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol. Oncol. 101 (2006) 470-475
58. Gallup D.G., and Stock R.J. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet. Gynecol. 64 (1984) 417-420